SEC Tracker
Get the app

Retension Pharmaceuticals RTSN

Retension Pharmaceuticals anticipated IPO price between $11 and $13 per share

Securities offering (amended)

Form
S-1/A
Filed
Importance
Routine
  1. Offers 3,300,000 shares of common stock
  2. Anticipated IPO price between $11 and $13 per share
  3. Plans to list on Nasdaq under symbol RTSN

Written from the S-1/A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Retension Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX